Abstract:e13597 Background: Accurate identification of tumor origin is crucial for effective diagnosis and treatment, particularly in cases of metastatic tumors. Interpretable machine learning models have displayed significant potential in addressing this problem when imaging and immunohistochemistry (IHC) examinations are ineffective. In this study, we developed a panel using gene expression profiles from various tumors and constructed a robust machine learning model for precise identification of tumor origin. Methods: RNA sequencing (RNA-seq) data of 9462 tumor samples originating from 21 different organs were collected from The Cancer Genome Atlas (TCGA). We conducted feature engineering through unsupervised clustering and differential gene expression analysis, selecting a refined panel of 164 genes from a pool of over 60,000 identifiers. Subsequently, a machine learning classifier grounded in Logistic regression (LR) was trained on 9462 samples with the constructed 164-gene panel. To enhance the adaptability of our model to this task, 10-fold cross-validation was employed in the multi-class mode. Two independent test sets, the Primary tumor set (PT, n=3420, including 19 tumor types) and the Metastatic tumor set (MTP, n=100, all originating from the prostate and spread to bone, liver, etc.), were established with samples from Gene Expression Omnibus (GEO) and other published studies. Notably, all samples underwent FPKM normalization and there was no overlap between training and testing samples. Model performance was assessed using accuracy, specificity, and sensitivity metrics. Results: The 164-gene expression panel achieved a cross-validation accuracy of 96.73%. In the assessment of the PT test set, our model achieved an overall 99.62% specificity, 92.31% accuracy and 89.79% sensitivity, exhibiting performance comparable to similar models in other studies. Additionally, our model accurately traced 91% of metastatic tumors in the MTP test set to the prostate, surpassing previous lines of work by a large margin. Conclusions: Gene expression patterns reveal organ-specific characteristics that could be used to identify tumor origin. The combination of a condensed yet comprehensive gene expression panel with a robust machine learning model serves as a promising tool for tumor diagnosis. Ongoing correlative studies aim to extend predictions from tissue organs to cancer subtypes.

Identiifcation and validation of a novel gene expression signature for diagnosing tumor tissue origin

Development and Clinical Validation of a 90-Gene Expression Assay for Identifying Tumor Tissue Origin

Pan-cancer Transcriptome Analysis Reveals a Gene Expression Signature for the Identification of Tumor Tissue Origin.

Common Human Cancer Genes Discovered by Integrated Gene-Expression Analysis

Identification and Validation of a 44-Gene Expression Signature for the Classification of Renal Cell Carcinomas.

Tumor origin identification through machine learning and gene expression profiling.

A Novel Coiled-Coil Domain Containing-Related Gene Signature for Predicting Prognosis and Treatment Effect of Breast Cancer.

Clinical validation of a 90-gene expression test for tumor tissue of origin diagnosis: a large-scale multicenter study of 1417 patients

TOD-CUP: a Gene Expression Rank-Based Majority Vote Algorithm for Tissue Origin Diagnosis of Cancers of Unknown Primary

92-Gene Molecular Profiling in Identification of Cancer Origin: a Retrospective Study in Chinese Population and Performance Within Different Subgroups.

RNA-Seq Accurately Identifies Cancer Biomarker Signatures to Distinguish Tissue of Origin.

Data from Identification and Validation of a Blood-Based 18-Gene Expression Signature in Colorectal Cancer

Identification Of Novel Biomarkers And Candidate Small Molecule Drugs In Non-Small-Cell Lung Cancer By Integrated Microarray Analysis

Identification of a new gene signature for prognostic evaluation in cervical cancer: based on cuproptosis-associated angiogenesis and multi-omics analysis

A Hallmark-Based Six-Gene Expression Signature to Assess Colorectal Cancer and Its Recurrence Risk.

Identification of Distinct Molecular Patterns and a Four-Gene Signature in Colon Cancer Based on Invasion-Related Genes

Identifying primary site of lung-limited Cancer of unknown primary based on relative gene expression orderings

Gene Expression Profiling for Diagnosis of Triple-Negative Breast Cancer: A Multicenter, Retrospective Cohort Study

Identification and Validation of an 8-Gene Expression Signature for Predicting High-Fuhrman Grade Renal Cell Carcinoma.

Identification and Validation of Novel Metastasis-Related Signatures of Clear Cell Renal Cell Carcinoma Using Gene Expression Databases.

Identification and Validation of an Immune-Related Gene Prognostic Signature for Clear Cell Renal Carcinoma